Navigation Links
URI scientists reveal mechanism that regulates cancer-causing gene
Date:3/26/2009

KINGSTON, R.I. March 26, 2009 Two University of Rhode Island scientists have revealed how a cancer causing protein is regulated by reactive oxygen species (ROS) -- a type of stress signal. Their findings provide new insight into how this protein normally behaves in human cells and may help in the design of drugs targeting specific cancers.

Doctoral student David J. Kemble and Professor Gongqin Sun in the URI Department of Cell and Molecular Biology are the first to provide a biochemical mechanism describing how certain protein tyrosine kinases sense and respond to oxidation. This sensing system was found to uniquely apply to two families of proteins implicated in numerous cancers: the Src and Fibroblast Growth Factor Receptor families of tyrosine kinases.

Their results were published online March 9 in the Proceedings of the National Academy of Sciences.

Src was the first enzyme identified as a cancer-causing gene in the early 1900's. For years scientists have been studying how the enzymes are expressed in cancer cells what do they do and what controls them.

According to Kemble and Sun, Src is a master regulator of cell function, controlling cell metabolism, division, and death. In normal cells, the function of Src is turned off, and it is turned on only when certain stimulatory signals activate it. When the regulatory mechanisms that control Src activity are disrupted, Src may be turned on all the time, which turns the host cell into a cancer cell. Thus, it is crucial to understand how Src function is controlled.

Reactive oxygen species have long been viewed as damaging byproducts of oxygen-based metabolism. However, it is now recognized that ROS are produced when the cells are under growth stimulation, and they in turn regulate other cellular events. Accumulating evidence indicates that ROS can directly regulate the function of Src function, and thus indirectly control many cellular processes. Y
'/>"/>

Contact: Todd McLeish
tmcleish@uri.edu
401-874-7892
University of Rhode Island
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Scientists ID New Biomarker for Prostate Cancer
2. Herpes: Scientists find cellular process that fights virus
3. New book chronicles the journeys of women physicians and scientists to fighting cancer
4. University of Washington scientists one step closer to stopping bone loss during spaceflight
5. New Book Chronicles the Journeys of Women Physicians and Scientists to the Front Lines of Fighting Cancer
6. Biotech company cofounded by BIDMC scientists targets natural killer T-cells
7. Scientists trial device to treat chemotherapy-related nausea
8. Scientists closer to understanding how to control high blood sugar
9. First Treatment for Muscular Dystrophy in Sight: Scientists Harness Exon-Skipping in Large Animal to Successfully Treat Duchenne Muscular Dystrophy
10. First treatment for muscular dystrophy in sight: Scientists successfully harness exon-skipping
11. Scientists find gene that modifies severity of cystic fibrosis lung disease

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/27/2009)... , SEATTLE, Nov. 27 Allrec...cord-high Thanksgiving traffic numbers, with more ...ing, providing a clear picture of what was served ...ge Thanksgiving meal in 2009 weighed in at 2,225 c...t year,s feast. According to the Allrecipes site, ...
(Date:11/26/2009)...RK, Nov. 27 With cold and flu seas...y good practices to control the spread of infectio...ve not only to keep ourselves healthy, but to avoi... Finerty, RN, MS, CIC (certified in infection-cont...ccupational health at Hospital for Special Surgery...
(Date:11/26/2009)...thrill when on an emotional rollercoaster, study f...ws) -- Call it the fear factor meets the jubilant ...ors -- especially those who root for the winning t...losely contested match and victory was in doubt, p...Chew on that this Thanksgiving weekend as you,re g...
(Date:11/26/2009)... Ennis & Ennis, P.A. is offering free n...Yaz and Yasmin birth control pills who have suffer...m, Stroke, Heart Attack or other related cardiac i...call toll free at 1-800-856-6405 or go to the firm...fill out an online case evaluation form. , ...
(Date:11/25/2009)...O, Nov. 25 /PRNewswire/ - Sentinelle Medical Inc.,...vanced visualization software launches a suite of ...s(TM) medical imaging software platform at this ye...annual meeting in Chicago, Nov. 30 - Dec. 5, 2009 ...e unique high quality images generated by Sentinel...
Breaking Medicine News(10 mins):Health News:It's Black Friday - Time to Shop Off the Calories! Allrecipes Finds Average Thanksgiving Meal Weighed in at 2,225 Calories 2Health News:It's Black Friday - Time to Shop Off the Calories! Allrecipes Finds Average Thanksgiving Meal Weighed in at 2,225 Calories 3Health News:It's Black Friday - Time to Shop Off the Calories! Allrecipes Finds Average Thanksgiving Meal Weighed in at 2,225 Calories 4Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 2Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 3Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 4Health News:Watching the Nail-Biting Big Game Hurts So Good 2Health News:Watching the Nail-Biting Big Game Hurts So Good 3Health News:Ennis & Ennis, P.A. Announces Nationwide Free, Confidential, Consultations For Users Of Yaz And Yasmin Birth Control Pills 2Health News:Ennis & Ennis, P.A. Announces Nationwide Free, Confidential, Consultations For Users Of Yaz And Yasmin Birth Control Pills 3Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 2Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 3Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 4
...o increase its health sector cooperation with Indi...utical products. "We hope to enhance cooperat...ke telemedicine, training and doctors' exchange pr... conference organised here by industry lobby Assoc...
... made this summer when the U.S. Food and Drug Admi...vent cervical cancer//. The vaccine was given the ...protect against human papillomavirus (HPV), a sexu...of the Society for Women’s Health Research and cha...
...redistributed to cope with a major influenza pande...ssue of the Medical Journal of Australia. // ...t, Sydney GP Dr Nick Collins and colleagues outlin...tages are recognised in some rural and outer metro...
...o are attending to babies born to drug-addicted mo...ing before the babies are discharged from the hosp...rgo treatment for drug addictions at the hospital ...abies in the special care nursery because they sho...
...a gene that could possibly be the reason behind br...nd taking a turn for the worse. // Melbourne ...y on mice discovered that a gene known as body mor... which was capable of offsetting breast tumors fro...
...rders, like hemophilia, is being used to control b...// The drug Recombinant Activated Factor VIII h...cations in non-hemophiliacs. It can cause heart at...lood loss. Jawed Fareed an expert in blood clo...
Other Medicine News:Health News:Triumphs and Hurdles for the New HPV Vaccine 2Health News:Triumphs and Hurdles for the New HPV Vaccine 3
(Date:11/25/2009)... Reportlinker.com announces that a ...alogue: ,, Pain Management - Global Trends ...anagement---Global-Trends.html ,, Widespread a...nagement clinics, and the advent of new drugs have...ment market. Healthcare reforms and reimbursement ...
(Date:11/25/2009)...v. 25 ChemoCentryx, Inc., announ... Company,s PROTECT-1 (the Prospective Randomized O...f Traficet-EN(TM) (CCX282-B) in patients with mode...al efficacy with a favorable safety and tolerabili...inical efficacy in the reduction of disease severi...
(Date:11/24/2009)...4 Quest Diagnostics Inco...der of diagnostic testing, information and service...21st Annual Piper Jaffray Healthcare Conference in... Wednesday, December 2, 2009 at 9:30 a.m. Eastern ...l reaffirm its 2009 guidance for revenue growth to...
Breaking Medicine Technology:Reportlinker Adds Pain Management - Global Trends 2Reportlinker Adds Pain Management - Global Trends 3Reportlinker Adds Pain Management - Global Trends 4Reportlinker Adds Pain Management - Global Trends 5Reportlinker Adds Pain Management - Global Trends 6ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 2ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 3ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 4ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 5ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 6Quest Diagnostics To Speak At The 21st Annual Piper Jaffray Healthcare Conference 2iMedX Announces Acquisition of Worldtech Inc 55211 1iMedX Announces Acquisition of Worldtech Inc 55211 2JNCI news brief 3A Melanosome dynamics and sensitivity of melanoma cells to chemotherapy 55208 1Smokers Cars Loaded With Nicotine 55205 1Smokers Cars Loaded With Nicotine 55205 2Smokers Cars Loaded With Nicotine 55205 3
...l provide a pre-recorded webcast for financial ana... to coincide with the American Pain Society,s,(APS...ata presentations on,investigational tapentadol im...l analgesic, will be presented for the first time ...pentadol researchers, will be,made available concu...
...rial results for NKTR-118 (oral PEG-naloxol) were ...this week at the Annual Meeting of the,American Pa...le-dose Phase,1 study, oral NKTR-118 was shown to ...bsorption and an extended half-life that is up to ...one., NKTR-118 is Nektar,s proprietary peripheral...
Other Medicine Technology:NKTR-118 Shows Substantial Oral Bioavailability and Extended Half-Life in Phase 1 Clinical Data Presented at American Pain Society Meeting 2NKTR-118 Shows Substantial Oral Bioavailability and Extended Half-Life in Phase 1 Clinical Data Presented at American Pain Society Meeting 3NKTR-118 Shows Substantial Oral Bioavailability and Extended Half-Life in Phase 1 Clinical Data Presented at American Pain Society Meeting 4NKTR-118 Shows Substantial Oral Bioavailability and Extended Half-Life in Phase 1 Clinical Data Presented at American Pain Society Meeting 5NKTR-118 Shows Substantial Oral Bioavailability and Extended Half-Life in Phase 1 Clinical Data Presented at American Pain Society Meeting 6
Microforceps: Horizontal Subretinal
Microforceps: Diamond Dusted Pointed
Microforceps: Serrated- Jaws
Microforceps : Asymmetrical Endgripping Forceps
Medicine Products: